RMD Resmed Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RMD

Price (delayed)

$218.27

Market cap

$31.49B

P/E Ratio

20.85

Dividend/share

$2.46

EPS

$10.47

Enterprise value

$30.84B

?
Relative Growth: Rel. Growth: 81
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 49
Relative Profitability: Rel. Profitability: 91

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies ...

Highlights
The price to earnings (P/E) is 40% lower than the 5-year quarterly average of 34.9 and 9% lower than the last 4 quarters average of 23.0
The gross profit has grown by 13% YoY
Resmed's quick ratio has decreased by 15% YoY and by 9% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.resmed.com
Peers: MDT TMO ELMD INGN

Key stats

What are the main financial stats of RMD

RMD stock price

How has the Resmed stock price performed over time
Intraday
-0.6%
1 week
-4.41%
1 month
-2.92%
1 year
-20.52%
YTD
-9.38%
QTD
12%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$5.65B
Gross profit
$3.45B
Operating income
$1.89B
Net income
$1.52B
Gross margin
61.1%
Net margin
26.9%
The gross profit has grown by 13% YoY
RMD's operating income is up by 12% YoY
The company's revenue rose by 10% YoY and by 2.1% QoQ
RMD's net income is up by 9% YoY

Price vs fundamentals

How does RMD's price correlate with its fundamentals

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
RMD P/E details
P/E
20.85
P/B
4.81
P/S
5.62
EV/EBIT
16.07
EV/EBITDA
14.26
EV/Sales
5.46
The price to earnings (P/E) is 40% lower than the 5-year quarterly average of 34.9 and 9% lower than the last 4 quarters average of 23.0
The EPS has increased by 10% YoY
RMD's P/B is 35% below its 5-year quarterly average of 7.4 and 11% below its last 4 quarters average of 5.4
RMD's equity is up by 10% year-on-year
The P/S is 25% lower than the 5-year quarterly average of 7.5 and 11% lower than the last 4 quarters average of 6.3
The company's revenue rose by 10% YoY and by 2.1% QoQ

Efficiency

How efficient is Resmed business performance
The company's return on invested capital rose by 17% YoY
Resmed's ROE has decreased by 6% YoY and by 2% from the previous quarter
The ROA has decreased by 5% YoY and by 2.2% from the previous quarter
The ROS has increased by 4.3% YoY

Dividends

What is RMD's dividend history
Dividend details
DPS
$2.46
Dividend yield
1.13%
Payout ratio
23.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Resmed financials performed over time
Resmed's quick ratio has decreased by 15% YoY and by 9% from the previous quarter
The current ratio has contracted by 10% YoY but it has grown by 3% from the previous quarter
Resmed's debt is 87% lower than its equity
RMD's equity is up by 10% year-on-year
Resmed's debt to equity has decreased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.